Samsung Biologics Reports Operating Profit of 91.7 Billion KRW Last Year, Up 64.6% YoY
[Asia Economy Reporter Song Seung-yoon] Samsung Biologics announced on the 22nd that its operating profit last year was 91.7 billion KRW, an increase of 64.6% compared to 2018.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
During the same period, sales revenue rose 30.9% to 701.6 billion KRW. On the other hand, net profit decreased by 9.5% to 202.9 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
